Evidence map›Paper›PMID 42684020›Full record

ReviewWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society

LRRC15+ Myofibroblasts as a Stromal State Linking Repair, Fibrosis, and Scarring.

Rabab S Hamad, Elsayed A Elmorsy, Attalla F El-Kott, Mohammed A AlShehri, Sally Negm, Waleed Eltantawy, Mohamed A M Ali, Anis Ahmad Chaudhary, Sameh Saber

Abstract readReview
In one paragraph

Review in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rabab S HamadBiological Sciences Department, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.ORCID https://orcid.org/0000-0002-3465-4470
Elsayed A ElmorsyDepartment of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah, Saudi Arabia.ORCID https://orcid.org/0000-0001-6165-3847
Attalla F El-KottDepartment of Biology, College of Science, King Khalid University, Abha, Saudi Arabia.ORCID https://orcid.org/0000-0001-5060-0790
Mohammed A AlShehriDepartment of Biology, College of Science, King Khalid University, Abha, Saudi Arabia.
Sally NegmHealth Specialties, Basic Sciences and Their Applications Unit, Applied College, Mahayil Asir, King Khalid University, Abha, Saudi Arabia.
Waleed EltantawyDepartment of Biology, Program of Preparatory Year, Batterjee Medical college, Aseer, Saudi Arabia.
Mohamed A M AliDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0001-8217-0262
Anis Ahmad ChaudharyDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-1506-7836
Sameh SaberDepartment of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.ORCID https://orcid.org/0000-0002-5070-7851

Funding

King Faisal University KFU264728
6 · The paper itself

Abstract

Fibroblasts are essential for tissue repair, but persistent activation of matrix-remodelling myofibroblasts can promote fibrosis, tissue stiffening and immune dysfunction. LRRC15 is a leucine-rich repeat-containing cell-surface protein enriched in selected activated mesenchymal compartments, with the strongest functional evidence arising from cancer-associated stroma. State-level evidence also links LRRC15 to a TGF-β-regulated extracellular matrix-remodelling myofibroblast state in idiopathic pulmonary fibrosis and to disease-specific myofibroblast programs in human skin, including inflamed hidradenitis suppurativa associated with scarring risk. However, LRRC15-specific causal evidence in physiological wound repair and pathological scarring remains limited. This review therefore considers LRRC15 positivity a context-dependent stromal state rather than a universal fibroblast lineage or intrinsically pathological identity. Focusing on pulmonary fibrosis and tumour stroma, with skin repair as a comparative framework, we integrate single-cell transcriptomics, spatial mapping, matrix biology and cancer immunology. Current evidence supports LRRC15 as a marker of activated stromal programs and, in selected tumour models, as a contributor to immunoregulatory stromal function, but does not establish universal control of fibroblast contractility, matrix persistence, or scar formation. We propose that temporal persistence and anatomical context may distinguish adaptive from maladaptive LRRC15-associated remodelling. Across tissues, these observations suggest related or convergent programs rather than a demonstrated conserved molecular identity. The proposed repair-to-pathology spectrum is therefore hypothesis-generating and requires validation through temporal lineage tracing, tissue-relevant LRRC15 perturbation, spatial protein analysis, and stage-specific therapeutic studies. LRRC15 is best viewed as a biological readout and potential targeting handle whose significance must be defined in each tissue context.

Indexed as

CicatrixMembrane ProteinsMyofibroblastsWound HealingAnimalsExtracellular MatrixFibrosisHumansMembrane Proteinsextracellular matrixfibroblast plasticityLRRC15myofibroblastpulmonary fibrosisskin scarring

Identifiers

PMID42684020
PMCPMC13536930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.